Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (29)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hou, S.-M.
Right arrow Articles by Lambert, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hou, S.-M.
Right arrow Articles by Lambert, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 3, 437-444, March 1999
© 1999 Oxford University Press

Hprt mutant frequency and aromatic DNA adduct level in non-smoking and smoking lung cancer patients and population controls

Sai-Mei Hou3, Ke Yang1, Fredrik Nyberg2, Kari Hemminki1, Göran Pershagen2 and Bo Lambert

Environmental Medicine Unit and
1 Molecular Epidemiology Unit, Department of Biosciences, Karolinska Institute, CNT/NOVUM, 141 57 Huddinge and
2 Division of Environmental Epidemiology, Institute of Environmental Medicine, Karolinska Institute, Box 210, 171 77 Stockholm, Sweden

T cell cloning and 32P-post-labelling methods were used to study the mutant frequency (MF) at the hypoxanthine-guanine phosphoribosyl transferase (hprt) locus and the aromatic DNA adduct level (AL) in peripheral lymphocytes of newly diagnosed lung cancer patients (92 ever-smokers and 87 never-smokers) and matched population controls (82 ever-smokers and 79 never-smokers). Overall, the MF (total mean 20.6x10–6) and AL (4.1x10–8) were similar in cases and controls with the same smoking status, indicating that the disease has limited effect on the two endpoints. When cases and controls were combined, the AL was significantly higher in current smokers than in former or never-smokers (P = 0.0003) and the MF was significantly higher in ever-smokers than in never-smokers (P = 0.004). Age affected the MF significantly in ever-smokers (1.6%/year, 95% CI 0.6–2.5, adjusted for packyears and years since last smoking), especially among cases (2.1%/year, 95% CI 0.5–3.7). An increase of AL with age was observed in currently smoking cases only (2.3%/year, 95% CI 0.3–4.2, adjusted for smoking dose). For currently smoking cases, there was also a more pronounced effect of smoking dose on both endpoints and a significant correlation between AL and MF (r = 0.52, P = 0.04) was observed among those with the highest dose. Our data also provide additional evidence for the different turnover times of smoking-induced DNA adducts and hprt mutations. The stronger increase of MF and AL with age and dose in currently smoking patients compared with controls is consistent with an interaction between smoking and genetic host factors.

Abbreviations: AL, adduct level; ETS, environmental tobacco smoke; hprt, hypoxanthine-guanine phosphoribosyl transferase; MF, mutant frequency; PAH, polycyclic aromatic hydrocarbon; TSL, time since last regular smoking.

3 To whom correspondence should be addressed Email: saimei.hou{at}cnt.ki.se


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
F. Veglia, S. Loft, G. Matullo, M. Peluso, A. Munnia, F. Perera, D. H. Phillips, D. Tang, H. Autrup, O. Raaschou-Nielsen, et al.
DNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis
Carcinogenesis, May 1, 2008; 29(5): 932 - 936.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Noori, S. Hou, I. M. Jones, C. B. Thomas, and B. Lambert
A comparison of somatic mutational spectra in healthy study populations from Russia, Sweden and USA
Carcinogenesis, June 1, 2005; 26(6): 1138 - 1151.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
S. Benhamou, A. Laplanche, B. Guillonneau, A. Mejean, F. Desgrandchamps, C. Schrameck, V. Degieux, and F. Perin
DNA adducts in normal bladder tissue and bladder cancer risk
Mutagenesis, September 1, 2003; 18(5): 445 - 448.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. Nyberg, S.-M. Hou, G. Pershagen, and B. Lambert
Dietary fruit and vegetables protect against somatic mutation in vivo, but low or high intake of carotenoids does not
Carcinogenesis, April 1, 2003; 24(4): 689 - 696.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
F. Veglia, G. Matullo, and P. Vineis
Bulky DNA Adducts and Risk of Cancer: A Meta-Analysis
Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 157 - 160.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. H. Phillips
Smoking-related DNA and protein adducts in human tissues
Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
F. Perera, K. Hemminki, W. Jedrychowski, R. Whyatt, U. Campbell, Y. Hsu, R. Santella, R. Albertini, and J. P. O'Neill
In Utero DNA Damage from Environmental Pollution Is Associated with Somatic Gene Mutation in Newborns
Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1134 - 1137.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S.-M. Hou, S. Falt, S. Angelini, K. Yang, F. Nyberg, B. Lambert, and K. Hemminki
The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk
Carcinogenesis, April 1, 2002; 23(4): 599 - 603.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. M. Whyatt, W. Jedrychowski, K. Hemminki, R. M. Santella, W.-Y. Tsai, K. Yang, and F. P. Perera
Biomarkers of Polycyclic Aromatic Hydrocarbon-DNA Damage and Cigarette Smoke Exposures in Paired Maternal and Newborn Blood Samples as a Measure of Differential Susceptibility
Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S.-M. Hou, S. Fält, K. Yang, F. Nyberg, G. Pershagen, K. Hemminki, and B. Lambert
Differential Interactions between GSTM1 and NAT2 Genotypes on Aromatic DNA Adduct Level and HPRT Mutant Frequency in Lung Cancer Patients and Population Controls
Cancer Epidemiol. Biomarkers Prev., February 1, 2001; 10(2): 133 - 140.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.